These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 38399222)

  • 1. Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives.
    Peng S; Wang W; Zhang R; Wu C; Pan X; Huang Z
    Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments.
    Gupta C; Jaipuria A; Gupta N
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research.
    Chan HW; Chow S; Zhang X; Zhao Y; Tong HHY; Chow SF
    AAPS PharmSciTech; 2023 Apr; 24(4):98. PubMed ID: 37016029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation devices: from basic science to practical use, innovative vs generic products.
    Pirozynski M; Sosnowski TR
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1559-1571. PubMed ID: 27267298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
    Forest V; Pourchez J
    Adv Drug Deliv Rev; 2022 Apr; 183():114173. PubMed ID: 35217112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Strategies for Improving the Bioavailability of Inhaled Pharmaceutical Formulations.
    Xing Y; Lu P; Xue Z; Liang C; Zhang B; Kebebe D; Liu H; Liu Z
    Mini Rev Med Chem; 2020; 20(13):1258-1271. PubMed ID: 32386491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhalable nanoparticulate powders for respiratory delivery.
    Muralidharan P; Malapit M; Mallory E; Hayes D; Mansour HM
    Nanomedicine; 2015 Jul; 11(5):1189-99. PubMed ID: 25659645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Updates in Inhalable Drug Delivery System against Various Pulmonary Diseases: Challenges and Future Perspectives.
    Chaudhary KR; Singh K; Singh C
    Curr Drug Deliv; 2024; 21(10):1320-1345. PubMed ID: 37870055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Sub-Micron Particle Based Aerosol Strategies for Efficient Systemic Delivery of Therapeutic Agents.
    Joshi N; Kaur S; Banerjee R
    Curr Pharm Des; 2016; 22(17):2470-80. PubMed ID: 26915832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs.
    Ramachandran S; Prakash P; Mohtar N; Kumar KS; Parumasivam T
    Pharm Dev Technol; 2023 Dec; 28(10):978-991. PubMed ID: 37937865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder inhalers in COPD, lung inflammation and pulmonary infections.
    Muralidharan P; Hayes D; Mansour HM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):947-62. PubMed ID: 25388926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.
    Khan I; Hussein S; Houacine C; Khan Sadozai S; Islam Y; Bnyan R; Elhissi A; Yousaf S
    Int J Pharm; 2021 Apr; 598():120376. PubMed ID: 33617949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Oxygen Flow on Aerosol Delivery From a Nebulizer With a Holding Chamber.
    Sarhan RM; Elberry AA; Abdelwahab NS; Rabea H; Salem MN; Abdelrahim ME
    Respir Care; 2019 Dec; 64(12):1508-1515. PubMed ID: 31387895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evolving perspective on novel modified release drug delivery systems for inhalational therapy.
    Hye T; Moinuddin SM; Sarkar T; Nguyen T; Saha D; Ahsan F
    Expert Opin Drug Deliv; 2023 Mar; 20(3):335-348. PubMed ID: 36720629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current therapies and technological advances in aqueous aerosol drug delivery.
    Watts AB; McConville JT; Williams RO
    Drug Dev Ind Pharm; 2008 Sep; 34(9):913-22. PubMed ID: 18663654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled Treprostinil Drug Delivery During Mechanical Ventilation and Spontaneous Breathing Using Two Different Nebulizers.
    Parker DK; Shen S; Zheng J; Ivy DD; Crotwell DN; Hotz JC; DiBlasi RM
    Pediatr Crit Care Med; 2017 Jun; 18(6):e253-e260. PubMed ID: 28441181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.
    Sharma A; Vaghasiya K; Gupta P; Singh AK; Gupta UD; Verma RK
    J Control Release; 2020 Aug; 324():17-33. PubMed ID: 32418903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of innovative microparticulate/nanoparticulate inhalable dry powders of a novel synthetic trifluorinated chalcone derivative and Nrf2 agonist.
    Muralidharan P; Jones B; Allaway G; Biswal SS; Mansour HM
    Sci Rep; 2020 Nov; 10(1):19771. PubMed ID: 33188247
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.